| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.014 | 0.8 |